HowShorted

How shorted is Contineum Therapeutics, Inc.?

10.58%
of shares outstanding reported short · settlement date 15 Jul 2026
vs previous report
+1.33
5 reports (~10 weeks)
+3.63
Aggregate net short position time series for Contineum Therapeutics, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
15 Jul 202610.58%+1.33
30 Jun 20269.25%+2.09
15 Jun 20267.16%+0.96
29 May 20266.20%+0.06
15 May 20266.14%−0.81
30 Apr 20266.95%−6.47
15 Apr 202613.42%+1.39
31 Mar 202612.03%+0.59
13 Mar 202611.44%+0.41
27 Feb 202611.03%−0.15
13 Feb 202611.18%−0.06
30 Jan 202611.24%+0.03
15 Jan 202611.21%+0.59
31 Dec 202510.62%+3.25
15 Dec 20257.37%+2.83
28 Nov 20254.54%−0.61
14 Nov 20255.15%−0.15
31 Oct 20255.30%+1.20
15 Oct 20254.10%−0.18
30 Sep 20254.28%+1.14
15 Sep 20253.14%+0.93
29 Aug 20252.21%+0.66
15 Aug 20251.55%+0.60
31 Jul 20250.95%–

Frequently asked questions

How shorted is Contineum Therapeutics, Inc. right now?
10.58% of Contineum Therapeutics, Inc.'s (CTNM) shares outstanding were reported short for settlement date 15 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.